These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 36499755)
1. GOLM1 and FAM49B: Potential Biomarkers in HNSCC Based on Bioinformatics and Immunohistochemical Analysis. Xi Y; Zhang T; Sun W; Liang R; Ganesh S; Chen H Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499755 [TBL] [Abstract][Full Text] [Related]
2. Identification and analysis of genes associated with head and neck squamous cell carcinoma by integrated bioinformatics methods. Jin Y; Yang Y Mol Genet Genomic Med; 2019 Aug; 7(8):e857. PubMed ID: 31304688 [TBL] [Abstract][Full Text] [Related]
3. Excavating novel diagnostic and prognostic long non-coding RNAs (lncRNAs) for head and neck squamous cell carcinoma: an integrated bioinformatics analysis of competing endogenous RNAs (ceRNAs) and gene co-expression networks. Yang L; Lu P; Yang X; Li K; Chen X; Qu S Bioengineered; 2021 Dec; 12(2):12821-12838. PubMed ID: 34898376 [TBL] [Abstract][Full Text] [Related]
4. Identification of SERPINE1, PLAU and ACTA1 as biomarkers of head and neck squamous cell carcinoma based on integrated bioinformatics analysis. Yang K; Zhang S; Zhang D; Tao Q; Zhang T; Liu G; Liu X; Zhao T Int J Clin Oncol; 2019 Sep; 24(9):1030-1041. PubMed ID: 30937621 [TBL] [Abstract][Full Text] [Related]
5. Identification of Potential Biomarkers and Survival Analysis for Head and Neck Squamous Cell Carcinoma Using Bioinformatics Strategy: A Study Based on TCGA and GEO Datasets. Shen Y; Liu J; Zhang L; Dong S; Zhang J; Liu Y; Zhou H; Dong W Biomed Res Int; 2019; 2019():7376034. PubMed ID: 31485443 [TBL] [Abstract][Full Text] [Related]
6. Identification of Novel Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma using Bioinformatics Analysis. Ding Y; Li M; Tayier T; Chen L; Feng S Comb Chem High Throughput Screen; 2021; 24(9):1351-1363. PubMed ID: 33109035 [TBL] [Abstract][Full Text] [Related]
7. Identity of MMP1 and its effects on tumor progression in head and neck squamous cell carcinoma. Zhang G; Li T; Tan G; Song Y; Liu Q; Wang K; Ai J; Zhou Z; Li W Cancer Med; 2022 Jun; 11(12):2516-2530. PubMed ID: 35426219 [TBL] [Abstract][Full Text] [Related]
8. Co-expression network-based identification of biomarkers correlated with the lymph node metastasis of patients with head and neck squamous cell carcinoma. Jin Y; Qin X Biosci Rep; 2020 Feb; 40(2):. PubMed ID: 32076707 [TBL] [Abstract][Full Text] [Related]
9. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma. Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a fourteen- innate immunity-related gene pairs signature for predicting prognosis head and neck squamous cell carcinoma. Zhang F; Liu Y; Yang Y; Yang K BMC Cancer; 2020 Oct; 20(1):1015. PubMed ID: 33081731 [TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic potential of PLEK2 in head and neck squamous cell carcinoma based on bioinformatics analysis. Wang J; Sun Z; Wang J; Tian Q; Huang R; Wang H; Wang X; Han F Cancer Med; 2021 Sep; 10(18):6515-6533. PubMed ID: 34331382 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive Analysis Identifies Hyaluronan Mediated Motility Receptor and Cell Division Cycle 25C as Potential Prognostic Biomarkers in Head and Neck Squamous Cell Carcinoma. Zhang H; Xu Y; Han H; Ye X; Cheng L; Shen Y; Wan X Cancer Control; 2024; 31():10732748241287904. PubMed ID: 39323031 [TBL] [Abstract][Full Text] [Related]
13. Identification of immune-related genes contributing to head and neck squamous cell carcinoma development using weighted gene co-expression network analysis. Guo Q; Lu T; Xu H; Luo Q; Liu Z; Jiang S; Pan J; Lin S; Lin M; Guo F Cancer Rep (Hoboken); 2023 May; 6(5):e1808. PubMed ID: 37092360 [TBL] [Abstract][Full Text] [Related]
14. GOLM1 predicts poor prognosis of patients with NSCLC and is associated with the proliferation and chemo-sensitivity of cisplatin in NSCLC cells: bioinformatics analysis and laboratory validation. Zhao M; Li X; Chen X J Bioenerg Biomembr; 2021 Apr; 53(2):177-189. PubMed ID: 33538941 [TBL] [Abstract][Full Text] [Related]
15. Screening and clinical significance of tumor markers in head and neck squamous cell carcinoma through bioinformatics analysis. Zhao L; Chi W; Cao H; Cui W; Meng W; Guo W; Wang B Mol Med Rep; 2019 Jan; 19(1):143-154. PubMed ID: 30431092 [TBL] [Abstract][Full Text] [Related]
16. UBE2C promotes the progression of head and neck squamous cell carcinoma. Jin Z; Zhao X; Cui L; Xu X; Zhao Y; Younai F; Messadi D; Hu S Biochem Biophys Res Commun; 2020 Mar; 523(2):389-397. PubMed ID: 31870550 [TBL] [Abstract][Full Text] [Related]
17. Investigation of miR-21-5p Key Target Genes and Pathways in Head and Neck Squamous Cell Carcinoma Based on TCGA Database and Bioinformatics Analysis. Shen M; Zhou Z; Li BB; Lv M; Feng C; Chen S; Shi S; Kang M; Zhao T Technol Cancer Res Treat; 2022; 21():15330338221081245. PubMed ID: 35235474 [No Abstract] [Full Text] [Related]
18. Integrative Analysis Reveals the Potential Role and Prognostic Value of GOLM1 in Hepatocellular Carcinoma. Lin Y; He Z; Gao X; Lu L; Lu C; Huang J; Luo M; Ye J; Liang R Oxid Med Cell Longev; 2022; 2022():8284500. PubMed ID: 36211823 [TBL] [Abstract][Full Text] [Related]
19. Tumor Mutation Burden, Immune Cell Infiltration, and Construction of Immune-Related Genes Prognostic Model in Head and Neck Cancer. Jiang AM; Ren MD; Liu N; Gao H; Wang JJ; Zheng XQ; Fu X; Liang X; Ruan ZP; Tian T; Yao Y Int J Med Sci; 2021; 18(1):226-238. PubMed ID: 33390791 [No Abstract] [Full Text] [Related]
20. Identification of prognostic marker genes in head and neck squamous cell carcinoma: A study based on The Cancer Genome Atlas database and experimental validation. Zhong Q; Zhou L; Zhu D J Oral Pathol Med; 2021 Oct; 50(9):891-901. PubMed ID: 33880801 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]